META · TRT & HORMONE

Advertising TRT on Meta: 2026 rules for testosterone & hormone brands

Requires certification Updated June 2026 Verify against live policy
The short answerTRT sits in a Meta gray zone: it falls under Prescription Drugs (naming testosterone/hormone Rx needs LegitScript + authorization, US/CA/NZ, 18+) and Unsafe Substances (anabolic steroids and HGH are prohibited outright). You cannot name testosterone, promise a prescription, or show vials/needles. Compliant brands advertise the evaluation, not the molecule.

Certification & authorization

To promote the hormone as an Rx: LegitScript + Meta authorization, US/CA/NZ, 18+ (by category inference - Meta has no clause literally naming “TRT”). Anabolic steroids and HGH are prohibited outright, so any ad reading as steroid/HGH promotion is banned, not restricted.

What’s prohibited

  • Naming testosterone, showing vials/needles, or promising to “boost your T”
  • Anything reading as anabolic-steroid or HGH promotion (prohibited outright)
  • Symptom/condition targeting or “Do you have low T?” copy
  • Before/after imagery and quantified outcome claims (“increase T by X%”)
  • Muscle-building / “get jacked” positioning (PED policy flag)

Disclaimers & landing-page requirements

RequirementsIf promoting the Rx, include the consult-a-professional/valid-prescription disclaimer. Route to a HIPAA-compliant educational landing page rather than a direct booking/Rx page; do the clinical work off the ad.

Top reasons ads get rejected

  • Reads as anabolic-steroid or HGH promotion
  • Naming the hormone Rx without certification + authorization
  • Symptom/condition targeting or “low T?” copy
  • Before/after or quantified outcome claims
  • Missing disclaimer or non-compliant landing page

What enforcement actually looks like

The costly failure mode is being sorted into the wrong policy bucket. Creative featuring vials, syringes, or “boost your T” framing risks being read as anabolic-steroid or HGH promotion - an unsafe-substances violation, which is prohibited outright - rather than as a restricted prescription-drug ad. The distinction matters at enforcement time: restricted-category rejections invite you to certify and resubmit, while unsafe-substances rejections stack toward ad-account disablement with a far weaker appeal position, because no compliant version of the ad exists to point to.

How compliant brands still advertise

The compliant pathRun educational “men’s wellness / vitality / energy” angles - no drug names, no numeric promises, no before/after. Send broad wellness creative to a HIPAA-compliant landing page that does the clinical work, and get LegitScript + Meta authorization if you intend to name the treatment. Gate to 18+.

This page covers Meta policy only. For CAC benchmarks, funnel structure, and creative strategy across the whole vertical, see TRT & hormone marketing: the full vertical playbook.

FAQ

No. Naming testosterone, promising a prescription, or “boost your T” claims get disapproved, and anything reading as steroid/HGH promotion is prohibited outright. Advertise the symptoms and the evaluation instead.

They run men’s-wellness/vitality education with no drug names, no before/after, and no numeric promises, driving to a HIPAA-compliant landing page that qualifies the patient - with LegitScript + authorization if they name the treatment.

Sources

Ad policies change frequently and enforcement is tightening - treat this as a starting point and confirm current requirements against each platform’s live policy and qualified counsel before launching. This is general information, not legal advice.

Launching trt & hormone ads on Meta?

We pre-clear every account and creative against Meta's health-vertical policy so your launch doesn't get rejected or your account disabled.

Book a free strategy call
30 minutes Free account audit Written plan either way
Book a free strategy call